134 related articles for article (PubMed ID: 37714833)
1. Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.
Wang CJ; Petersone L; Edner NM; Heuts F; Ovcinnikovs V; Ntavli E; Kogimtzis A; Fabri A; Elfaki Y; Houghton LP; Hosse RJ; Schubert DA; Frei AP; Ross EM; Walker LSK
Nat Commun; 2023 Sep; 14(1):5724. PubMed ID: 37714833
[No Abstract] [Full Text] [Related]
2. Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.
Wang CJ; Petersone L; Edner NM; Heuts F; Ovcinnikovs V; Ntavli E; Kogimtzis A; Fabri A; Elfaki Y; Houghton LP; Hosse RJ; Schubert DA; Frei AP; Ross EM; Walker LSK
Nat Commun; 2022 Nov; 13(1):6757. PubMed ID: 36347877
[TBL] [Abstract][Full Text] [Related]
3. Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells.
Takahashi T; Tibell A; Ljung K; Saito Y; Gronlund A; Osterholm C; Holgersson J; Lundgren T; Ericzon BG; Corbascio M; Kumagai-Braesch M
Stem Cells Transl Med; 2014 Dec; 3(12):1484-94. PubMed ID: 25313200
[TBL] [Abstract][Full Text] [Related]
4. Costimulation blockade induces foxp3(+) regulatory T cells to human embryonic stem cells.
Ljung K; Simonson OE; Felldin U; Wärdell E; Ibarra C; Antonsson L; Kumagai-Braesch M; Hovatta O; Lampela R; Grinnemo KH; Corbascio M
Biores Open Access; 2013 Dec; 2(6):455-8. PubMed ID: 24380056
[TBL] [Abstract][Full Text] [Related]
5. Predicting clinical response to costimulation blockade in autoimmunity.
Edner NM; Wang CJ; Petersone L; Walker LSK
Immunother Adv; 2021 Jan; 1(1):ltaa003. PubMed ID: 36017489
[TBL] [Abstract][Full Text] [Related]
6. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.
Mangada J; Pearson T; Brehm MA; Wicker LS; Peterson LB; Shultz LD; Serreze DV; Rossini AA; Greiner DL
Diabetes; 2009 Jan; 58(1):165-73. PubMed ID: 18984741
[TBL] [Abstract][Full Text] [Related]
7. Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade.
Krummey SM; Floyd TL; Liu D; Wagener ME; Song M; Ford ML
J Immunol; 2014 Mar; 192(5):2495-504. PubMed ID: 24493820
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
[TBL] [Abstract][Full Text] [Related]
9. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.
Ferrari-Lacraz S; Zheng XX; Kim YS; Li Y; Maslinski W; Li XC; Strom TB
J Immunol; 2001 Sep; 167(6):3478-85. PubMed ID: 11544341
[TBL] [Abstract][Full Text] [Related]
10. Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart.
Grinnemo KH; Genead R; Kumagai-Braesch M; Andersson A; Danielsson C; Månsson-Broberg A; Dellgren G; Strömberg AM; Ekberg H; Hovatta O; Sylvén C; Corbascio M
Stem Cells; 2008 Jul; 26(7):1850-7. PubMed ID: 18467659
[TBL] [Abstract][Full Text] [Related]
11. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
12. Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.
Cvetkovski F; Razavi R; Sellberg F; Berglund E; Berglund D
Am J Transplant; 2023 Oct; 23(10):1603-1611. PubMed ID: 37270108
[TBL] [Abstract][Full Text] [Related]
13. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation by costimulation blockade inhibits rejection of nerve allografts.
Kvist M; Lemplesis V; Kanje M; Ekberg H; Corbascio M; Dahlin LB
J Peripher Nerv Syst; 2007 Jun; 12(2):83-90. PubMed ID: 17565532
[TBL] [Abstract][Full Text] [Related]
15. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P
J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399
[TBL] [Abstract][Full Text] [Related]
16. Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy.
Linhart B; Bigenzahn S; Hartl A; Lupinek C; Thalhamer J; Valenta R; Wekerle T
J Immunol; 2007 Mar; 178(6):3924-31. PubMed ID: 17339493
[TBL] [Abstract][Full Text] [Related]
17. IL-35 and Autoimmunity: a Comprehensive Perspective.
Choi J; Leung PS; Bowlus C; Gershwin ME
Clin Rev Allergy Immunol; 2015 Dec; 49(3):327-32. PubMed ID: 25619872
[TBL] [Abstract][Full Text] [Related]
18. Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen.
Gattringer M; Baranyi U; Pilat N; Hock K; Klaus C; Ramsey HE; Wrba F; Valenta R; Wekerle T
Clin Exp Allergy; 2016 Feb; 46(2):354-64. PubMed ID: 26464312
[TBL] [Abstract][Full Text] [Related]
19. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
20. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
